- Home
- QSI vs ARCT Comparison
QSI vs ARCT Comparison
Compare QSI & ARCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QSI
- ARCT
- Stock Information
- Founded
- QSI 2013
- ARCT 2013
- Country
- QSI United States
- ARCT United States
- Employees
- QSI N/A
- ARCT N/A
- Industry
- QSI Biotechnology: Pharmaceutical Preparations
- ARCT Biotechnology: Pharmaceutical Preparations
- Sector
- QSI Health Care
- ARCT Health Care
- Exchange
- QSI Nasdaq
- ARCT Nasdaq
- Market Cap
- QSI 334.9M
- ARCT 298.3M
- IPO Year
- QSI N/A
- ARCT N/A
- Fundamental
- Price
- QSI $1.71
- ARCT $13.27
- Analyst Decision
- QSI Strong Buy
- ARCT Strong Buy
- Analyst Count
- QSI 3
- ARCT 8
- Target Price
- QSI $2.38
- ARCT $52.83
- AVG Volume (30 Days)
- QSI 8.7M
- ARCT 474.4K
- Earning Date
- QSI 08-05-2025
- ARCT 08-04-2025
- Dividend Yield
- QSI N/A
- ARCT N/A
- EPS Growth
- QSI N/A
- ARCT N/A
- EPS
- QSI N/A
- ARCT N/A
- Revenue
- QSI $3,443,000.00
- ARCT $143,680,000.00
- Revenue This Year
- QSI $77.57
- ARCT N/A
- Revenue Next Year
- QSI $251.34
- ARCT $34.79
- P/E Ratio
- QSI N/A
- ARCT N/A
- Revenue Growth
- QSI 167.94
- ARCT 15.38
- 52 Week Low
- QSI $0.61
- ARCT $8.04
- 52 Week High
- QSI $5.77
- ARCT $25.88
- Technical
- Relative Strength Index (RSI)
- QSI 45.67
- ARCT 51.35
- Support Level
- QSI $1.67
- ARCT $13.25
- Resistance Level
- QSI $1.89
- ARCT $15.20
- Average True Range (ATR)
- QSI 0.12
- ARCT 0.97
- MACD
- QSI -0.04
- ARCT -0.04
- Stochastic Oscillator
- QSI 5.88
- ARCT 30.20
About QSI Quantum-Si Incorporated
Quantum-Si Inc is a life sciences company focused on the development and commercialization of proteomics research tools. The company has designed and developed a hardware, consumable, and software solution to provide a solution for protein detection and analysis. It has developed a proprietary universal single-molecule detection platform that enables Next-Generation Protein Sequencing (NGPS), the ability to sequence proteins.
About ARCT Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in one business segment, which includes all activities related to the discovery, development and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU, and LUNAR-COV19.